Geode Capital Management LLC Sells 1,981 Shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR)

Geode Capital Management LLC reduced its stake in Nature’s Sunshine Products, Inc. (NASDAQ:NATR) by 0.7% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 288,976 shares of the company’s stock after selling 1,981 shares during the period. Geode Capital Management LLC owned 1.56% of Nature’s Sunshine Products worth $3,937,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Jacobs Levy Equity Management Inc. grew its holdings in Nature’s Sunshine Products by 7.7% during the third quarter. Jacobs Levy Equity Management Inc. now owns 67,258 shares of the company’s stock valued at $916,000 after purchasing an additional 4,820 shares during the period. Bank of New York Mellon Corp grew its holdings in shares of Nature’s Sunshine Products by 12.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 48,589 shares of the company’s stock valued at $732,000 after buying an additional 5,425 shares during the period. Renaissance Technologies LLC increased its position in shares of Nature’s Sunshine Products by 1.9% in the 2nd quarter. Renaissance Technologies LLC now owns 559,797 shares of the company’s stock valued at $8,436,000 after buying an additional 10,700 shares in the last quarter. XTX Topco Ltd acquired a new stake in Nature’s Sunshine Products during the 2nd quarter worth $180,000. Finally, Barclays PLC lifted its holdings in Nature’s Sunshine Products by 51.8% during the third quarter. Barclays PLC now owns 35,602 shares of the company’s stock worth $485,000 after acquiring an additional 12,152 shares in the last quarter. 79.40% of the stock is owned by institutional investors and hedge funds.

Nature’s Sunshine Products Price Performance

NATR opened at $14.71 on Tuesday. The company has a market capitalization of $271.78 million, a price-to-earnings ratio of 16.72 and a beta of 0.96. The business’s 50-day moving average price is $15.30 and its two-hundred day moving average price is $14.53. Nature’s Sunshine Products, Inc. has a 1 year low of $10.81 and a 1 year high of $21.72.

Insider Activity at Nature’s Sunshine Products

In related news, major shareholder Fosun Pharmaceutical Shanghai sold 3,000 shares of the stock in a transaction on Thursday, October 10th. The shares were sold at an average price of $13.39, for a total transaction of $40,170.00. Following the completion of the transaction, the insider now owns 69,347 shares in the company, valued at approximately $928,556.33. This represents a 4.15 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 4.70% of the stock is owned by insiders.

Analysts Set New Price Targets

NATR has been the subject of several recent analyst reports. Canaccord Genuity Group began coverage on Nature’s Sunshine Products in a report on Friday, September 13th. They issued a “buy” rating and a $18.00 price target for the company. StockNews.com raised Nature’s Sunshine Products from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, September 10th. Finally, Canaccord Genuity Group assumed coverage on shares of Nature’s Sunshine Products in a research note on Friday, September 13th. They issued a “buy” rating and a $18.00 price target on the stock.

Nature’s Sunshine Products Company Profile

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.